|
Ischemic biology - basic studies
Citations 151-160 of 336 total displayed.
|
Past content
(since Jan 1999):
|
- UltraRapid Communications
Inhibition of Cytochrome P450 -Hydroxylase: A Novel Endogenous Cardioprotective Pathway
- Kasem Nithipatikom, Eric R. Gross, Michael P. Endsley, Jeannine M. Moore, Marilyn A. Isbell, John R. Falck, William B. Campbell, and Garrett J. Gross
Circ. Res. 2004;95:e65-71e; published online before print as doi:10.1161/01.RES.0000146277.62128.6f
[Abstract]
[Full text]
- Articles
Silent Information Regulator 2 , a Longevity Factor and Class III Histone Deacetylase, Is an Essential Endogenous Apoptosis Inhibitor in Cardiac Myocytes
- Ralph R. Alcendor, Lorrie A. Kirshenbaum, Shin-ichiro Imai, Stephen F. Vatner, and Junichi Sadoshima
Circ. Res. published October 14, 2004, doi:10.1161/01.RES.0000147557.75257.ff
[Abstract]
- Integrative Physiology
Transgenic Expression of Bcl-2 Modulates Energy Metabolism, Prevents Cytosolic Acidification During Ischemia, and Reduces Ischemia/Reperfusion Injury
- Kenichi Imahashi, Michael D. Schneider, Charles Steenbergen, and Elizabeth Murphy
Circ. Res. 2004;95:734-741; published online before print as doi:10.1161/01.RES.0000143898.67182.4c
[Abstract]
[Full text]
- Ultrarapid Communication
Inhibition of Cytochrome P450 -Hydroxylase. A Novel Endogenous Cardioprotective Pathway
- Kasem Nithipatikom, Eric R. Gross, Michael P. Endsley, Jeannine M. Moore, Marilyn A. Isbell, John R. Falck, William B. Campbell, and Garrett J. Gross
Circ. Res. published September 23, 2004, doi:10.1161/01.RES.0000146277.62128.6f
[Abstract]
- Articles
Transgenic Expression of Bcl-2 Modulates Energy Metabolism, Prevents Cytosolic Acidification During Ischemia, and Reduces Ischemia/Reperfusion Injury
- Kenichi Imahashi, Michael D. Schneider, Charles Steenbergen, and Elizabeth Murphy
Circ. Res. published September 2, 2004, doi:10.1161/01.RES.0000143898.67182.4c
[Abstract]
- Reports
Postconditioning: A Form of "Modified Reperfusion" Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase-Akt Pathway
- Andrew Tsang, Derek J. Hausenloy, Mihaela M. Mocanu, and Derek M. Yellon
Circ. Res. 2004;95:230-232; published online before print as doi:10.1161/01.RES.0000138303.76488.fe
[Abstract]
[Full text]
- Cellular Biology
Selective Inhibition of Inward Rectifier K+ Channels (Kir2.1 or Kir2.2) Abolishes Protection by Ischemic Preconditioning in Rabbit Ventricular Cardiomyocytes
- Roberto J. Diaz, Carsten Zobel, Hee Cheol Cho, Michelle Batthish, Alina Hinek, Peter H. Backx, and Gregory J. Wilson
Circ. Res. 2004;95:325-332; published online before print as doi:10.1161/01.RES.0000137727.34938.35
[Abstract]
[Full text]
- Molecular Medicine
Novel Mechanism of Action for Hydralazine: Induction of Hypoxia-Inducible Factor-1 , Vascular Endothelial Growth Factor, and Angiogenesis by Inhibition of Prolyl Hydroxylases
- Helen J. Knowles, Ya-Min Tian, David R. Mole, and Adrian L. Harris
Circ. Res. 2004;95:162-169; published online before print as doi:10.1161/01.RES.0000134924.89412.70
[Abstract]
[Full text]
- Reviews
Mesenchymal Stem Cells and Their Potential as Cardiac Therapeutics
- Mark F. Pittenger and Bradley J. Martin
Circ. Res. 2004;95:9-20, doi:10.1161/01.RES.0000135902.99383.6f
[Abstract]
[Full text]
- Molecular Medicine
Vascular Endothelial Growth Factor Overexpression in Ischemic Skeletal Muscle Enhances Myoglobin Expression In Vivo
- Vincent van Weel, Martine M.L. Deckers, Jos M. Grimbergen, Kees J.M. van Leuven, JanWillem H.P. Lardenoye, Reinier O. Schlingemann, Geerten P. van Nieuw Amerongen, J. Hajo van Bockel, Victor W.M. van Hinsbergh, and Paul H.A. Quax
Circ. Res. 2004;95:58-66; published online before print as doi:10.1161/01.RES.0000133247.69803.c3
[Abstract]
[Full text]
|
|